Gene expressions of TRP channels in glioblastoma multiforme and relation with survival

Tumor Biology

Volumn 36, Issue 12, 2015, Pages 9209-9213

  Alptekin, M ^a   Eroglu, S ^a   Tutar, E ^a   Sencan, S ^a   Geyik, M A ^a   Ulasli, M ^a   Demiryurek, A T ^a   Camci, C ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Glioblastoma multiforme; Survival; TRP channels

Indexed keywords

TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL 4; TRANSIENT RECEPTOR POTENTIAL CHANNEL 5; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; TRANSIENT RECEPTOR POTENTIAL CHANNEL 7; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M2; TRANSIENT RECEPTOR POTENTIAL CHANNEL M3; TRANSIENT RECEPTOR POTENTIAL CHANNEL M4; TRANSIENT RECEPTOR POTENTIAL CHANNEL M5; TRANSIENT RECEPTOR POTENTIAL CHANNEL M6; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 2; VANILLOID RECEPTOR 3; VANILLOID RECEPTOR 4; VANILLOID RECEPTOR 5; MESSENGER RNA;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL TIME; TRPA1 GENE; TRPC GENE; TRPC1 GENE; TRPC3 GENE; TRPC4 GENE; TRPC5 GENE; TRPC6 GENE; TRPC7 GENE; TRPM1 GENE; TRPM2 GENE; TRPM3 GENE; TRPM4 GENE; TRPM5 GENE; TRPM6 GENE; TRPM7 GENE; TRPM8 GENE; TRPV1 GENE; TRPV2 GENE; TRPV3 GENE; TRPV4 GENE; TRPV5 GENE; TRPV7 GENE; AGED; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; MULTIGENE FAMILY; PATHOLOGY; SURVIVAL ANALYSIS;

AGED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; MULTIGENE FAMILY; RNA, MESSENGER; SURVIVAL ANALYSIS; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 84952873757     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3577-x     Document Type: Article

References (47)

1. Giese A, Westphal M. Glioma invasion in the central nervous system. Neurosurgery. 1996;39(2):235–50. discussion 50–2.
2. Mahaley Jr MS, Mettlin C, Natarajan N, Laws Jr ER, Peace BB. National survey of patterns of care for brain-tumor patients. J Neurosurg. 1989;71(6):826–36.
3. Ohgaki H, Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol. 2007;170(5):1445–53. doi:10.2353/ajpath.2007.070011.
4. Surawicz TS, McCarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990–1994. Neuro-Oncology. 1999;1(1):14–25.
5. Berens M, Rutka J, Rosenblum M. Brain tumor epidemiology, growth, and invasion. Neurosurg Clin N Am. 1990;1(1):1–18.
6. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, et al. Malignant glioma: genetics and biology of a grave matter. Genes Dev. 2001;15(11):1311–33.
7. Ohgaki H. Genetic pathways to glioblastomas. Neuropathology. 2005;25(1):1–7.
8. Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre P-L, et al. Genetic pathways to glioblastoma: a population-based study. Cancer Res. 2004;64(19):6892–9.
9. Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, et al. Long-term survival with glioblastoma multiforme. Brain. 2007;130(10):2596–606.
10. Nilius B, Owsianik G. The transient receptor potential family of ion channels. Genome Biol. 2011;12(3):218.
11. Ouadid-Ahidouch H, Dhennin-Duthille I, Gautier M, Sevestre H, Ahidouch A. TRP channels: diagnostic markers and therapeutic targets for breast cancer? Trends Mol Med. 2013;19(2):117–24.
12. Zimmermann H. Neurotransmitter release. FEBS Lett. 1990;268(2):394–9.
13. Capiod T. The need for calcium channels in cell proliferation. Recent Pat Anticancer Drug Discov. 2013;8(1):4–17.
14. Naranjo JR, Mellström B. Ca2+-dependent transcriptional control of Ca2+ homeostasis. J Biol Chem. 2012;287(38):31674–80.
15. Pinton P, Giorgi C, Siviero R, Zecchini E, Rizzuto R. Calcium and apoptosis: ER-mitochondria Ca2 & plus; transfer in the control of apoptosis. Oncogene. 2008;27(50):6407–18.
16. Roderick HL, Cook SJ. Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival. Nat Rev Cancer. 2008;8(5):361–75.
17. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol. 2003;4(7):517–29.
18. Nielsen N, Lindemann O, Schwab A. TRP channels and STIM/ORAI proteins: sensors and effectors of cancer and stroma cell migration. Br J Pharmacol. 2014;171(24):5524–40.
19. Numata T, Ogawa N, Takahashi N, Mori Y. TRP channels as sensors of oxygen availability. Pflugers Arch Eur J Physiol. 2013;465(8):1075–85.
20. Chigurupati S, Venkataraman R, Barrera D, Naganathan A, Madan M, Paul L, et al. Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasiveness. Cancer Res. 2010;70(1):418–27.
21. Yamamoto S, Shimizu S, Kiyonaka S, Takahashi N, Wajima T, Hara Y, et al. TRPM2-mediated Ca2+ influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration. Nat Med. 2008;14(7):738–47.
22. Tochhawng L, Deng S, Pervaiz S, Yap CT. Redox regulation of cancer cell migration and invasion. Mitochondrion. 2013;13(3):246–53.
23. Bauer I, Grozio A, Lasigliè D, Basile G, Sturla L, Magnone M, et al. The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses. J Biol Chem. 2012;287(49):40924–37.
24. Link TM, Park U, Vonakis BM, Raben DM, Soloski MJ, Caterina MJ. TRPV2 has a pivotal role in macrophage particle binding and phagocytosis. Nat Immunol. 2010;11(3):232–9.
25. Zhao Z, Ni Y, Chen J, Zhong J, Yu H, Xu X, et al. Increased migration of monocytes in essential hypertension is associated with increased transient receptor potential channel canonical type 3 channels. PloS One. 2012;7(3):e32628.
26. Su L, Liu W, Chen H, González-Pagán O, Habas R, Runnels L. TRPM7 regulates polarized cell movements. Biochem J. 2011;434:513–21.
27. Damann N, Owsianik G, Li S, Poll C, Nilius B. The calcium-conducting ion channel transient receptor potential canonical 6 is involved in macrophage inflammatory protein-2-induced migration of mouse neutrophils. Acta Physiol. 2009;195(1):3–11.
28. Lindemann O, Umlauf D, Frank S, Schimmelpfennig S, Bertrand J, Pap T, et al. TRPC6 regulates CXCR2-mediated chemotaxis of murine neutrophils. J Immunol. 2013;190(11):5496–505.
29. Ramsey IS, Delling M, Clapham DE. An introduction to TRP channels. Annu Rev Physiol. 2006;68:619–47.
30. Kiselyov K, Soyombo A, Muallem S. TRPpathies. J Physiol. 2007;578(3):641–53.
31. Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor potential cation channels in disease. Physiol Rev. 2007;87(1):165–217.
32. Gkika D, Prevarskaya N. Molecular mechanisms of TRP regulation in tumor growth and metastasis. Biochim Biophys Acta (BBA)-Mol Cell Res. 2009;1793(6):953–8.
33. Prevarskaya N, Zhang L, Barritt G. TRP channels in cancer. Biochim Biophys Acta (BBA)-Mol Basis Dis. 2007;1772(8):937–46.
34. Wısnoskey B, Sınkıns W, Schıllıng W. Activation of vanilloid receptor type I in the endoplasmic reticulum fails to activate store-operated Ca2+ entry. Biochem J. 2003;372:517–28.
35. Xu X-ZS, Moebius F, Gill DL, Montell C. Regulation of melastatin, a TRP-related protein, through interaction with a cytoplasmic isoform. Proc Natl Acad Sci. 2001;98(19):10692–7.
36. Amantini C, Mosca M, Nabissi M, Lucciarini R, Caprodossi S, Arcella A, et al. Capsaicin-induced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation. J Neurochem. 2007;102(3):977–90.
37. Nabissi M, Morelli MB, Amantini C, Farfariello V, Ricci-Vitiani L, Caprodossi S, et al. TRPV2 channel negatively controls glioma cell proliferation and resistance to Fas-induced apoptosis in ERK-dependent manner. Carcinogenesis. 2010;31(5):794–803.
38. Ishii M, Oyama A, Hagiwara T, Miyazaki A, Mori Y, Kiuchi Y, et al. Facilitation of H2O2-induced A172 human glioblastoma cell death by insertion of oxidative stress-sensitive TRPM2 channels. Anticancer Res. 2007;27(6B):3987–92.
39. Morelli MB, Nabissi M, Amantini C, Farfariello V, Ricci-Vitiani L, di Martino S, et al. The transient receptor potential vanilloid-2 cation channel impairs glioblastoma stem-like cell proliferation and promotes differentiation. Int J Cancer. 2012;131(7):E1067–77.
40. Stock K, Kumar J, Synowitz M, Petrosino S, Imperatore R, Smith ESJ, et al. Neural precursor cells induce cell death of high-grade astrocytomas through stimulation of TRPV1. Nat Med. 2012;18(8):1232–8.
41. Bomben VC, Sontheimer H. Disruption of transient receptor potential canonical channel 1 causes incomplete cytokinesis and slows the growth of human malignant gliomas. Glia. 2010;58(10):1145–56.
42. Ding X, He Z, Zhou K, Cheng J, Yao H, Lu D, et al. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma. J Natl Cancer Inst. 2010;102(14):1052–68.
43. Zamudio-Bulcock PA, Everett J, Harteneck C, Valenzuela CF. Activation of steroid-sensitive TRPM3 channels potentiates glutamatergic transmission at cerebellar Purkinje neurons from developing rats. J Neurochem. 2011;119(3):474–85.
44. Liu M, Inoue K, Leng T, Guo S, Xiong Z-G. TRPM7 channels regulate glioma stem cell through STAT3 and Notch signaling pathways. Cell Signal. 2014;26(12):2773–81.
45. Wondergem R, Ecay TW, Mahieu F, Owsianik G, Nilius B. HGF/SF and menthol increase human glioblastoma cell calcium and migration. Biochem Biophys Res Commun. 2008;372(1):210–5.
46. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997;389(6653):816–24.
47. Nabissi M, Morelli MB, Santoni M, Santoni G. Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents. Carcinogenesis. 2013;34(1):48–57.